Publications
- Aggressive acute myeloid leukemia in PU.1/p53 double-mutant mice2014 | First Faculty of Medicine
- Combined Approach to Leukemic Differentiation Using Transcription Factor PU.1-Enhancing Agents2022 | First Faculty of Medicine
- Prediction Potential of Serum miR-155 and miR-24 for Relapsing Early Breast Cancer2017 | First Faculty of Medicine, Faculty of Mathematics and Physics
- Plasma miR-155, miR-203, and miR-205 are Biomarkers for Monitoring of Primary Cutaneous T-Cell Lymphomas2017 | First Faculty of Medicine, Faculty of Mathematics and Physics
- Oncogenic MicroRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum2014 | First Faculty of Medicine, Faculty of Mathematics and Physics
- 5-Azacitidine in aggressive myelodysplastic syndromes regulates chromatin structure at PU.1 gene and cell differentiation capacity2012 | First Faculty of Medicine
- MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia2011 | First Faculty of Medicine
- PU.1 Activation Relieves GATA-1-Mediated Repression of Cebpa and Cbfb during Leukemia Differentiation2009 | First Faculty of Medicine
- Delineating aggressiveness of acute myeloid leukemia in a mouse model carrying mutations of Spi1 (PU.1) and Trp53Publication without faculty affiliation
- Oncogenic microRNAs to predict relapse in early breast cancer patientsPublication without faculty affiliation
Loading network view...